3rd ESTRO Forum 2015 the verification of treatment delivery. Using the real-time cumulative χ we are able to demonstrate an improved ability to identify small but potentially significant positional errors when compared to using only the integrated image χ value.
Purpose/Objective: Proton computed tomography (CT) has been described as a solution to image the proton relative stopping power (RSP) of patient tissues and could therefore reduce the uncertainty and associated margins of the conversion of X-ray CT images to RSP maps. Several studies have already demonstrated the capability of proton imaging to reconstruct tissue RSP but the quantification of the improvement with respect to X-ray CT is still missing. This study aimed at quantifying the accuracy of RSP maps reconstructed from X-ray and proton CT and their impact on the prediction of proton ranges under idealized conditions, i.e., perfect detectors for the position and the energy of protons and realistic but perfectly known X-ray source and flat panel.
Materials and Methods:
We have developed a Monte Carlo framework to assess proton CT performances for the main steps of a proton therapy treatment planning, i.e., proton or X-ray CT acquisition and reconstruction, conversion to RSP maps based on the calibration of a tissue phantom, and proton dose simulations. The RSP maps obtained from X-ray CT images rely on the calibration curve that converts Hounsfield units into RSP. Two different approaches (linear interpolation and least-squares minimization) were tested to determine the impact of this calibration. In-silico pencil beams were simulated to a computational phantom on various anatomical sites and the proton range was assessed on the reference, the proton CT-based and the X-ray CTbased material maps. Results: The imaging dose delivered by a proton CT scanner appeared impressively uniform and conformal to the imaging beam. Comparison of the RSP maps showed that proton CT enables a more precise RSP reconstruction of all anatomical sites (Figure 1 ). The spatial distribution of the RSP deviation also shows that the accuracy of proton CT reconstruction is more uniform. This weaker tissue dependence could help to produce a more robust estimate of the proton range between patients. As expected from the RSP reconstruction, proton CT gave a more precise estimate of the proton range with a mean range deviation of only 0.3%, which was at least 60% smaller than the X-ray CT predictions. Figure 1 . Absolute deviation of the RSP for liver, head and lungs sites for proton CT (left) and for X-ray CT using a linearly interpolated calibration (middle) or a least-squares fit (right). Conclusions: A Monte Carlo framework has been developed to assess the performances of proton CT for the simulation of the patient dose in proton therapy. Considering ideal detectors performances, the reconstructed RSP maps with proton CT were more accurate than the RSP maps obtained from X-ray CT images. Proton range calculations based on proton CT are therefore both more precise and more uniform with a weaker dependence to the spatial distribution of tissues. Smaller treatment margins could therefore be used if proton CT was available to plan proton therapy. Proton CT also benefits from the uniformity of the imaging dose distribution and its high conformation to the primary beam region.
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Proton induced x-ray fluorescence CT (pXFCT) imaging: a step towards proton beam range detection M. Bazalova-Carter 1 , M. Ahmad 1 , T. Matsuura 2 , S. Takao 2 , Y. Matsuo 2 , R. Fahrig 3 , H. Shirato 2 , K. Umegaki 2 , L. Xing 1 1 Stanford University, Department of Radiation Oncology, Stanford, USA 2 Hokkaido University Hospital, Proton Beam Therapy Center, Sapporo, Japan 3 Stanford University, Department of Radiology, Stanford, USA Purpose/Objective: Particle induced x-ray emission (PIXE), commonly based on detection of characteristic x-rays upon irradiation with a low-energy proton beam, is a useful tool for high-sensitivity material analysis of thin samples. We propose to investigate the feasibility of proton induced x-ray fluorescence (pXRF) for range verification in proton therapy. The goal of this work was to demonstrate the feasibility of proton-induced x-ray fluorescence CT (pXFCT) imaging of gold placed in a phantom by means of experiments and Monte Carlo (MC) simulations. Materials and Methods: First, proton induced gold x-ray fluorescence (pXRF) was measured as a function of gold concentration. Vials of 2.2 cm in diameter filled with 0-5% Au solutions were irradiated with a 3×10 11 220 MeV protons of 7mm FWHM. X-ray fluorescence induced by the interaction of protons and Au was detected with a 3×3 mm 2 CdTe detector placed at 90° with respect to the incident proton beam at a distance of 45 cm from the vials. Second, a 7-cm diameter water phantom containing three 2.2-diameter vials with 3%, 4%, and 5% Au solutions was imaged with the 7-mm 220 MeV proton beam in a 1st generation CT scanning geometry (Figure 1a ). 21 translational steps spaced by 3 mm at each of
